X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/arthex-biotech-receives-ind-clearance-from-fda-to-initiate-the-phase-i-iia-arthemir-trial-of-atx-01-for-myotonic-dystrophy-type-1-dm1-302073670.html
https://www.prnewswire.com/news-releases/arthex-biotech-announces-presentations-at-the-19th-annual-meeting-of-the-oligonucleotide-therapeutics-society-ots-and-tides-europe-2023-301966056.html
https://www.prnewswire.com/news-releases/arthex-biotech-to-present-at-chardans-7th-annual-genetic-medicines-conference-301941693.html
https://www.prnewswire.com/news-releases/arthex-biotech-to-present-preclinical-data-on-atx-01-for-myotonic-dystrophy-type-1-dm1-at-tides-usa-2023-meeting-301819961.html
https://endpts.com/arthex-nabs-series-b-for-clinical-trial-of-aso-in-myotonic-dystrophy/
https://www.prnewswire.com/news-releases/arthex-announces-regulatory-milestones-met-in-its-program-to-develop-atx-01-in-myotonic-dystrophy-type-1-301702312.html
https://www.prnewswire.com/news-releases/arthex-biotech-appoints-frederic-legros-phd-as-executive-chairman-of-the-board-301687256.html
Market Place
Share 
